| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.62B | 42.08B | 44.43B | 44.52B | 57.82B | 35.05B |
| Gross Profit | 13.97B | 13.37B | 12.79B | 10.61B | 12.27B | 10.28B |
| EBITDA | 21.07B | 20.05B | 19.91B | 20.46B | 19.43B | 16.68B |
| Net Income | 9.73B | 9.56B | 8.45B | 9.14B | 8.71B | 7.12B |
Balance Sheet | ||||||
| Total Assets | 426.83B | 419.54B | 405.98B | 398.33B | 376.21B | 381.35B |
| Cash, Cash Equivalents and Short-Term Investments | 21.63B | 25.34B | 28.42B | 27.91B | 28.23B | 29.70B |
| Total Debt | 248.32B | 245.68B | 222.67B | 222.04B | 202.24B | 211.73B |
| Total Liabilities | 308.40B | 301.54B | 280.33B | 279.01B | 256.93B | 262.71B |
| Stockholders Equity | 118.43B | 118.00B | 125.65B | 119.32B | 119.28B | 118.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.05B | 919.00M | -14.88B | 15.91B | -17.40B |
| Operating Cash Flow | 0.00 | 16.67B | 19.11B | 23.36B | 34.13B | 9.49B |
| Investing Cash Flow | 0.00 | -24.84B | -19.36B | -40.25B | -20.70B | -30.20B |
| Financing Cash Flow | 0.00 | 7.72B | 280.00M | 13.99B | -15.49B | 24.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥994.10B | 25.41 | 11.06% | 2.88% | 11.00% | 88.70% | |
78 Outperform | ¥4.76T | 18.13 | 10.15% | 1.86% | 18.31% | 71.89% | |
74 Outperform | ¥1.24T | 9.43 | 19.43% | 5.16% | 5.16% | 6.00% | |
72 Outperform | ¥1.21T | 9.44 | 19.60% | 1.94% | 3.13% | 11.87% | |
71 Outperform | ¥5.41T | 11.76 | 7.67% | 1.18% | 7.97% | 13.59% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥159.87B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% |